Lani Ibarra

Chief Tech/Sci/R&D Officer at STRUCTURE THERAPEUTICS INC.

Health Technology

Consumer Services

Commercial Services

Profile

Lani Ibarra is currently working as the Senior VP-Clinical Development Operations at Structure Therapeutics, Inc. Previously, Lani held positions as the Vice President-Clinical Operations at Dynavax Technologies Corp., Vice President-Global Clinical Operations at Molecular Partners AG, and Vice President-Global Clinical Operations at Molecular Partners,.
Inc. Lani obtained a graduate degree from Stanford University and an undergraduate degree from the University of California, Berkeley.

Lani Ibarra active positions

Companies	Position	Start
STRUCTURE THERAPEUTICS INC.	Chief Tech/Sci/R&D Officer	-

All active positions of Lani Ibarra

Former positions of Lani Ibarra

Companies	Position	End
MOLECULAR PARTNERS AG	Chief Tech/Sci/R&D Officer	-
Molecular Partners, Inc. Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz.	Corporate Officer/Principal	-
DYNAVAX TECHNOLOGIES CORPORATION	Chief Tech/Sci/R&D Officer	-

See the detail of Lani Ibarra's experience

Training of Lani Ibarra

Stanford University	Graduate Degree
University of California, Berkeley	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lani Ibarra's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	3
DYNAVAX TECHNOLOGIES CORPORATION	Health Technology
STRUCTURE THERAPEUTICS INC.	Commercial Services
MOLECULAR PARTNERS AG	Health Technology

Private companies	1
Molecular Partners, Inc. Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz.	Health Technology

See company connections